(Q43685643)
Statements
1 reference
Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus (English)
1 reference
Pan CQ
1 reference
Dodge TH
1 reference
Baker DL
1 reference
Prince WS
1 reference
Sinicropi DV
1 reference
Lazarus RA
1 reference
1 July 1998
1 reference
1 reference
273
1 reference
29
1 reference
18374-18381
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference